Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis
Personalis’s liquid biopsy is a part of a rising marketplace for minimal residual illness assays, checks that search for any ...
Personalis’s liquid biopsy is a part of a rising marketplace for minimal residual illness assays, checks that search for any ...
Together with the reverse merger, Candid Therapeutics introduced $505 million in non-public financing to help its pipeline of T cell ...
Credit: Unsplash/CC0 Public Domain The health advice that keeps you from getting sick might actually harm you once you're already ...
The New Mexico Department of Health (NMDOH) yesterday said it is investigating a measles outbreak at a correctional facility in ...
Companies all across the healthcare industry are looking to scale their AI abilities, often striking multi-year collaborations with Big Tech ...
MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to ...
As H5N1 avian flu outbreaks in commercial and backyard poultry across the United States continue at a brisk pace, the ...
unoL / iStock CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) yesterday announced an award of $3.3 million to Pittsburgh-based Peptilogics to ...
The Louisiana Department of Health (LDH) today announced that a patient previously hospitalized with a severe H5N1 avian flu infection ...
The US Department of Health and Human Services (HHS) today announced that it is awarding $306 million more in funding ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.